Inhibition of endothelial cell migration by cerivastatin, an HMG‐CoA reductase inhibitor: contribution to its anti‐angiogenic effect
Open Access
- 25 April 2001
- journal article
- Published by Wiley in FEBS Letters
- Vol. 495 (3) , 159-166
- https://doi.org/10.1016/s0014-5793(01)02337-7
Abstract
Recent studies have suggested that inhibitors of 3‐hydroxy‐3‐methyl‐glutaryl‐coenzyme A reductase (statins) can play a role in protection against vascular risk, which is independent of cholesterol re...Keywords
This publication has 28 references indexed in Scilit:
- Ongoing trials with matrix metalloproteinase inhibitorsExpert Opinion on Investigational Drugs, 2000
- Follow-up study of patients randomized in the scandinavian simvastatin survival study (4S) of cholesterol loweringThe American Journal of Cardiology, 2000
- Lipopolysaccharide Activates Matrix Metalloproteinase-2 in Endothelial Cells through an NF-κB-Dependent PathwayBiochemical and Biophysical Research Communications, 2000
- The Suppression of Small GTPase Rho Signal Transduction Pathway Inhibits Angiogenesis in Vitro and in VivoBiochemical and Biophysical Research Communications, 2000
- Isoprenoid‐Mediated Inhibition of Mevalonate Synthesis: Potential Application to CancerProceedings of the Society for Experimental Biology and Medicine, 1999
- Subcellular Localization of RhoA and Ezrin at Membrane Ruffles of Human Endothelial Cells: Differential Role of Collagen and FibronectinExperimental Cell Research, 1999
- Oncogenic Ha-Ras-induced Signaling Activates NF-κB Transcriptional Activity, Which Is Required for Cellular TransformationJournal of Biological Chemistry, 1997
- Hypercholesterolemia and angiogenesisThe American Journal of Cardiology, 1993
- HMEC-1: Establishment of an Immortalized Human Microvascular Endothelial Cell LineJournal of Investigative Dermatology, 1992
- A geranylgeranyltransferase for rhoA p21 distinct from the farnesyltransferase for ras p21ABiochemical and Biophysical Research Communications, 1991